rintatolimod
Showing 1 - 11 of 11
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022
Post COVID-19 Condition, Long COVID Trial (Rintatolimod, Placebo / Normal Saline)
Not yet recruiting
- Post COVID-19 Condition
- Long COVID
- Rintatolimod
- Placebo / Normal Saline
- (no location specified)
Oct 20, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Biopsy
- +7 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 23, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Best Practice
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 1, 2022
Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)
Active, not recruiting
- Triple -Negative Breast Cancer
- +4 more
- Biopsy
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Aug 1, 2022
Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,
Completed
- Metastatic Carcinoma in the Liver
- +4 more
- Celecoxib
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 25, 2022
Ovarian Cancer Recurrent Trial in Pittsburgh (Rintatolimod, Pembrolizumab, Cisplatin)
Recruiting
- Ovarian Cancer Recurrent
- Rintatolimod
- +2 more
-
Pittsburgh, PennsylvaniaMagee-Womens Hospital of UPMC
Mar 3, 2022
Pancreatic Cancer Trial (Rintatolimod)
Not yet recruiting
- Pancreatic Cancer
- Rintatolimod
- (no location specified)
Aug 8, 2022
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in
Suspended
- Anatomic Stage 0 Breast Cancer AJCC v8
- +18 more
- Celecoxib
- +6 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 4, 2022
HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (HER-2/neu peptide vaccine,
Completed
- HER2-positive Breast Cancer
- +7 more
- HER-2/neu peptide vaccine
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 4, 2020
Malignant Tumor of Pancreas Metastatic to Peritoneal Surface, Malignant Peritoneal Mesothelioma, Peritoneal Carcinomatosis Trial
Completed
- Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface
- +2 more
- DC vaccine
- +3 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 6, 2020